Professor Peter Rothwell

About

Professor Rothwell is a clinical neurologist with particular interests in stroke, hypertension, the risks and benefits of aspirin, and how best to apply the results of clinical trials and other research to clinical decisions with individual patients in routine clinical practice.  He leads the longitudinal Oxford Vascular Study, the findings of which have changed how people are assessed and treated after a transient ischaemic attack (TIA) or stroke, both in the UK and around the world. TIAs are now seen as medical emergencies requiring urgent treatment. Taking aspirin straight after a TIA, Professor Rothwell’s team showed, can reduce the chance of a major stroke over the next few days by 80%.

Professor Rothwell holds various advisory roles relating to stroke, including for the National Stroke Strategy, the Stroke Association, the National Institute for Health and Care Excellence, and he serves on several conference scientific committees. He is the author of over 300 published scientific papers and several books.